Wednesday, April 17, 2013

2551
Endocrinology and So Much More: Kidneys, Bones, Islets and Ovaries
8:30 am - 4:30 pm             6.5 CMLE Credits

Joely Straseski, PhD, MS, MT(ASCP), DABCC
Assistant Professor of Pathology, University of Utah School of Medicine; Medical Director, Endocrinology, ARUP Laboratories, Salt Lake City, UT


Emphasizing the role that laboratorians play in the health care team is important, so this workshop will focus on the clinical utility of endocrinology laboratory measurements and how these results impact patient care.  Additionally, staying abreast of new technologies and available assays is critical to advancing your knowledge base and further career development. Because endocrinology is a complex topic, this session is designed to provide information in this extremely important area by breaking down relevant topics to enhance understanding.

Common laboratory tests that are critical for the diagnosis of renal insufficiencies will be reviewed and their usefulness examined.  In addition, newer markers of renal disease will be discussed, including cystatin C and revised glomerular filtration rate equations such as CKD-Epi.  Issues with current creatinine measurements including specificity, standardization and traceability will be reviewed. 

A general review of calcium homeostasis will highlight the role of parathyroid hormone, phosphorus, and bone resorption and formation.  Consequences of hyper- and hypocalcemia and related laboratory tests will be outlined.  The advantages and disadvantages of intra-operative parathyroid testing will also be discussed.  The subject of calcium naturally leads into a discussion of Vitamin D, the role this hormone plays in regulating calcium levels, and the complex nomenclature associated with Vitamin D testing.  Health benefits and risks of Vitamin D supplementation will be presented, including current recommendations and issues with determining reference intervals for this analyte.

Exocrine and endocrine pancreatic function will be reviewed, including products of endocrine function.  This introduction to the islet cells and their products will provide the background necessary to further discuss diabetes testing and management.  Guidelines for diagnosis and the currently available tests used to monitor diabetic patients will also be reviewed.

You will get an overview of male and female reproductive hormones and their regulation.  Discussion will focus on the laboratory tests used to assess a variety of disease states, from amenorrhea and hypogonadism, to polycystic ovary syndrome, to monitoring testosterone therapy, to measurements of infertility and ovarian reserve.  This broad topic will also highlight some of the newer markers of reproductive function, such as anti-mullerian hormone and the inhibins.

Following this workshop, you will be able to:

  

4750    The Elements of a Quality Plan
8:30 am - 4:30 pm        6.5 CMLE Credits

Christine M. Gryko, MT(ASCP), CQA
Laboratory QA Supervisor, Pathology and Laboratory Medicine, Roswell Park Cancer Institute, Buffalo, NY


Because neglect for laboratory policies can lead to inaccurate patient results which reduce the quality of patient care, regulatory agencies require each laboratory to set up, maintain, and apply a quality assurance (QA) plan based on established quality system elements. All laboratorians need to understand their lab’s quality improvement initiatives and be knowledgeable about their responsibility for ensuring quality patient results.

At this workshop, you will gain the tools to build a quality management plan that meets regulatory agency requirements. You will be introduced to appropriate, easy-to-use methods that all staff can follow to perform follow-up investigations of errors and to communicate remedial actions taken. And, you will discover how all laboratorians can participate in correcting the root cause of an incident.

You will leave this workshop with the ability to create and organize your own quality manual, organize collaborative efforts with nursing to decrease pre-analytical errors, and develop templates to help control variables in processes, including patient testing and proficiency testing follow-up.

Following this workshop, you will be able to:


5785     White Blood Cell Disorders-Correlation of Morphology with Clinical and Laboratory Data
8:30 am - 4:00 pm      6.0 CMLE Credits

Andrew N. Young, MD, PhD, FASCP
Director of Clinical Laboratories, Grady Health System; Associate Professor, Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA

Failure to recognize malignant white cells (WBC) and correlate findings with clinical and other laboratory data can result in delayed diagnosis and treatment for the patient. Are you confident in your WBC morphology skills? Attend this workshop to provide the best possible patient care through a detailed review of the morphologic findings in white cell disorders, along with introductory material that will help you correlate morphologic findings with clinical and other laboratory data.

A presentation on benign conditions will be followed by an in-depth discussion on neoplastic diseases, organized along the lines of the current World Health Organization (WHO) classification of hematopoietic and lymphoid tumors, which correlates cell morphology with clinical data, flow cytometry, and molecular or cytogenetic findings. Different tumors in the WHO system require different therapies, so appropriate classification is very important. This presentation will also provide you with the basics of classification plus introductory information on relevant flow cytometry and molecular genetic tests. You’ll also gain skills in communicating with clinicians, and in organizing specimens for ancillary tests.


Following this workshop, you will be able to: